RxDoctor Payments Data

Matthew Anderson, MD

Orthopaedic Surgery · Franklin, TNNPI 1689105538

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (44.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 51.6% of the total. Reporting peaked in 2023 at $29,085 and has fallen 81.6% since, to $5,359 in 2025.

$47,266in general payments, 2019–2025

Across 143 payments — averaging $330.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$24K
  • Smith+Nephew$13K
  • Curiteva, Inc.$3K
  • Stryker$2K
  • Alpha Orthopedic Systems$1K
  • Medical Device Business Services, Inc.$1K
  • plus $3K from 9 others

What the payments were for

  • Grants$20,93844%
  • Travel & lodging$8,93219%
  • Food & beverage$4,4599%
  • Education$12,93827%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,266 in reported general payments places this provider in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.

See all orthopaedic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$80,126
Medicare patients
199
Services billed
2,305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone47$258
Ondansetron OdtOndansetron12$100
Oxycodone Hcl24$88
Meloxicam28$55
Tramadol Hcl19$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →